71 – 80 of 781
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
In silico analysis and experimental validation shows negative correlation between miR-1183 and cell cycle progression gene 1 expression in colorectal cancer
- Contribution to journal › Article
-
Mark
Sustained delivery of a heterodimer bone morphogenetic protein-2/7 via a collagen hydroxyapatite scaffold accelerates and improves critical femoral defect healing
- Contribution to journal › Article
-
Mark
Ligand Sulfur Oxidation State Progressively Alters Galectin-3-Ligand Complex Conformations To Induce Affinity-Influencing Hydrogen Bonds
- Contribution to journal › Article
-
Mark
Complement Components in Peripheral Blood from Adult Patients with IDH Wild-Type Glioblastoma
- Contribution to journal › Article
-
Mark
Editorial : Current challenges in complement diagnostics
- Contribution to journal › Debate/Note/Editorial
-
Mark
Safety and pharmacokinetics of GB1211, an oral galectin-3 inhibitor : a single- and multiple-dose first-in-human study in healthy participants
- Contribution to journal › Article
- 2022
-
Mark
Galectin-3 inhibitor GB0139 protects against acute lung injury by inhibiting neutrophil recruitment and activation
- Contribution to journal › Article
-
Mark
Editorial : Methods and applications in inflammation pharmacology
- Contribution to journal › Debate/Note/Editorial
-
Mark
Discovery and Optimization of the First Highly Effective and Orally Available Galectin-3 Inhibitors for Treatment of Fibrotic Disease
- Contribution to journal › Article
-
Mark
Lipid bilayer composition as a determinant of cancer cell sensitivity to tumoricidal protein-lipid complexes
- Contribution to journal › Article
